Business · India Bureau
Centre mandates qualified personnel for pharmaceutical batch clearance
The central government has proposed regulatory amendments requiring qualified professionals to oversee drug batch release, aiming to reinforce accountability and quality standards across India's pharmaceutical manufacturing sector.
LSN India ·
New amendments to pharmaceutical regulations will mandate that only qualified personnel can authorize the release of drug batches from manufacturing facilities, according to government proposals under review. The move forms part of broader efforts to strengthen quality control measures and enhance oversight in India's drug production industry.
Under the proposed framework, manufacturers will be required to designate trained and certified personnel responsible for batch release decisions. These individuals must verify that products meet prescribed quality standards and comply with regulatory specifications before distribution to the market.
The amendments also emphasize maintenance of comprehensive records throughout the batch release process. Documentation requirements are designed to create an auditable trail that regulatory authorities can examine, establishing clear accountability at each stage of pharmaceutical manufacturing and quality assurance.
Government officials indicated the changes address gaps in current manufacturing practices and align India's standards with international pharmaceutical quality guidelines. The proposed regulations are expected to reduce instances of substandard or counterfeit drugs entering the supply chain while improving traceability for regulatory investigations.
The amendments are currently under government consideration and are expected to be finalized following consultation with industry stakeholders and pharmaceutical manufacturers across the country.